Elevated CRP, typically measured with high-sensitivity assays (hsCRP), is linked to poor prognosis in HF patients, with an increased mortality risk 12 months after discharge, independent of other CV risk factors [183,184]. This evidence concerns the gene CRP and hydrops fetalis.